Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
270 results found
2023 ∙ Scheffer, M. M. J. Coffeng, L. E. O'Mahony, J. F.
Appropriateness of strategy comparisons in cost-effectiveness analyses of infant pneumococcal vaccination: A systematic review
Newborn Pneumococcal disease Economic aspects
Rating:
Not applicable
2023 ∙ Du, Yuanze Wang, Yi Zhang, Ting Li, Juanjuan Song, Hewei Wang, Yuanyuan Xu, Yifei Cui, Jingwen Yang, Ming Wang, Zengwu Wu, Xiuyun Wang, Chunping
Economic evaluations of 13-valent pneumococcal conjugate vaccine: a systematic review
All age groups Pneumococcal disease Economic aspects
Rating:
Not applicable
2023 ∙ Del Riccio, M. Boccalini, S. Cosma, C. Vaccaro, G. Bonito, B. Zanella, B. Salvati, C. Giorgetti, D. Rigon, L. Biamonte, M. A. Monami, M. Bonanni, P. Bechini, A.
Effectiveness of pneumococcal vaccination on hospitalization and death in the adult and older adult diabetic population: a systematic review
Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Low
2023 ∙ Wannarong, T. Ekpatanaparnich, P. Boonyasiri, A. Supapueng, O. Vathanophas, V. Tanphaichitr, A. Ungkanont, K.
Efficacy of Pneumococcal Vaccine on Otitis Media: A Systematic Review and Meta-Analysis
Newborn Children Pneumococcal disease Efficacy/effectiveness
Rating:
Low
2023 ∙ Feng, S. McLellan, J. Pidduck, N. Roberts, N. Higgins, J. P. T. Choi, Y. Izu, A. Jit, M. Madhi, S. A. Mulholland, K. Pollard, A. J. Temple, B. Voysey, M.
Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data
Newborn Children Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Low
2023 ∙ Addario, A. Célarier, T. Bongue, B. Barth, N. Gavazzi, G. Botelho-Nevers, E.
Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65 years: a systematic review
Older adults Influenza Pneumococcal disease Herpes zoster Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Patel, J. Noureldin, M. Fakhouri, D. Farraye, F. A. Kovar-Gough, I. Warren, B. Waljee, A. K. Piper, M. S.
Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Adults Older adults Pneumococcal disease Coverage
Rating:
Not applicable
2023 ∙ Geraghty, K. Rooney, D. Watson, C. Ledwidge, M. T. Glynn, L. Gallagher, J.
Non-specific effects of Pneumococcal and Haemophilus vaccines in children aged 5 years and under: a systematic review
Newborn Children Pneumococcal disease Haemophilus influenzae type B Efficacy/effectiveness
Rating:
Low
2023 ∙ Arya, S. Norton, N. Kaushik, P. Brandtmuller, A. Tsoumani, E.
Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: A systematic review of published and grey literature
Europe Adults Older adults Pneumococcal disease Coverage
Rating:
Not applicable
2023 ∙ Farrar, J. L. Childs, L. Ouattara, M. Akhter, F. Britton, A. Pilishvili, T. Kobayashi, M.
Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults
Americas United States of America Adolescents Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
Loading...